Skip to main content
. 2018 Aug 23;42(5):2329–2342. doi: 10.3892/ijmm.2018.3836

Figure 9.

Figure 9

Anti-obesity and anti-hyperglycemic effects of CAA in ob/ob mice. Mice were administered with 8 mg/kg/day of CAA or vehicle for 12 days. (A) FBG and (B) BW were measured on days 0, 5 and 12. Oral glucose tolerance tests were performed in mice treated with CAA or vehicle on days 0 (C) and 12 (D). Data are expressed as the mean ± standard error of the mean (n=6). *P<0.05 and **P<0.01, vs. day 0. CAA, cajanonic acid A; FBG, fasting blood glucose.